
0.7375 Delayed Data As of May 27 | ![]() Today’s Change | 0.60 Today|||52-Week Range 4.54 | -41.93% Year-to-Date |
The 5 analysts offering 12-month price forecasts for Spectrum Pharmaceuticals Inc have a median target of 4.00, with a high estimate of 10.00 and a low estimate of 3.00. The median estimate represents a +442.37% increase from the last price of 0.74.
The current consensus among 5 polled investment analysts is to Buy stock in Spectrum Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.